These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28340113)

  • 1. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
    Lee WY; Weinberg OK; Pinkus GS
    Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of GATA1 dysfunction to multi-step leukemogenesis.
    Shimizu R; Yamamoto M
    Cancer Sci; 2012 Dec; 103(12):2039-44. PubMed ID: 22937757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
    Maitta RW; Wolgast LR; Wang Q; Zhang H; Bhattacharyya P; Gong JZ; Sunkara J; Albanese JM; Pizzolo JG; Cannizzaro LA; Ramesh KH; Ratech H
    Am J Hematol; 2011 Feb; 86(2):230-4. PubMed ID: 21264917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-1 is expressed in acute erythroblastic leukaemia.
    Ekert H; Sievers EL; Tan A; Martin DI; Smith FO; Barnard D; Bernstein ID
    Br J Haematol; 1994 Feb; 86(2):410-2. PubMed ID: 8199039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
    Ling T; Crispino JD; Zingariello M; Martelli F; Migliaccio AR
    Expert Rev Hematol; 2018 Mar; 11(3):169-184. PubMed ID: 29400094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Comparative Sensitivity of Immunohistochemical Markers of Megakaryocytic Differentiation in Acute Megakaryoblastic Leukemia.
    Klairmont MM; Hoskoppal D; Yadak N; Choi JK
    Am J Clin Pathol; 2018 Oct; 150(5):461-467. PubMed ID: 30052718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
    Ajore R; Dhanda RS; Gullberg U; Olsson I
    BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia.
    Leonards K; Almosailleakh M; Tauchmann S; Bagger FO; Thirant C; Juge S; Bock T; Méreau H; Bezerra MF; Tzankov A; Ivanek R; Losson R; Peters AHFM; Mercher T; Schwaller J
    Nat Commun; 2020 Jun; 11(1):2807. PubMed ID: 32533074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.
    Lee WY; Weinberg OK; Evans AG; Pinkus GS
    Am J Clin Pathol; 2018 Mar; 149(4):300-309. PubMed ID: 29481579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
    Miyauchi J; Ito Y; Tsukamoto K; Takahashi H; Ishikura K; Sugita K; Miyashita T
    Br J Haematol; 2010 Mar; 148(6):898-909. PubMed ID: 20064153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.
    Wang C; Hu M; Yu K; Liu W; Hu A; Kuang Y; Huang L; Gajendran B; Zacksenhaus E; Xiao X; Ben-David Y
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38695236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of erythroid-specific genes in megakaryoblastic disorders.
    Ito E; Kasai M; Toki T; Arai K; Yokoyama M
    Leuk Lymphoma; 1996 Nov; 23(5-6):545-50. PubMed ID: 9031085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.
    Yu H; Pinkus JL; Pinkus GS
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):51-6. PubMed ID: 25611244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
    Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
    PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.
    Stachura DL; Chou ST; Weiss MJ
    Blood; 2006 Jan; 107(1):87-97. PubMed ID: 16144799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
    Ohmori S; Takai J; Ishijima Y; Suzuki M; Moriguchi T; Philipsen S; Yamamoto M; Ohneda K
    Mol Cell Biol; 2012 Dec; 32(23):4742-55. PubMed ID: 22988301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proto-oncogene ERG in megakaryoblastic leukemias.
    Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
    Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
    Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
    PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues.
    Kaumeyer BA; Fidai SS; Thakral B; Wang SA; Arber DA; Cheng JX; Gurbuxani S; Venkataraman G
    Am J Clin Pathol; 2022 Aug; 158(2):228-234. PubMed ID: 35311938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.